BioSpace News Archive

Pressure BioSciences, Inc. today announced the Company’s participation as a presenter at the May 3-5 Planet MicroCap Showcase 2022.

Suneva Medical, Inc. (“Suneva” or the “Company”), and partner Bimini Health Tech (“Bimini”), today announced that they have received approval from Canada’s Medical Devices Directorate to market the Dermapose® all-in-one fat sizing syringe in Canada. In the U.S., Suneva has also received an additional 510(K) clearance from the U.S. Food and Drug Administration (FDA) for its larger volume 30 mL Amplifine PRP gel tube.

Affini-T Therapeutics, Inc. today announced that data from its KRAS program will be presented in an oral presentation at the 25th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT).

Bayer today announced the U.S. Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) and granted Priority Review for the oral androgen receptor inhibitor (ARi) NUBEQA ® .

iSono Health, Inc. today announced U.S. Food and Drug Administration (FDA) clearance of the company’s ATUSA™ System.

Brain injury-assessment device innovator BrainScope announced today that Diku Mandavia, MD, has joined the company as Chief Medical Officer. With 28 years of emergency medicine experience and 15 years of commercial medical device experience, Dr. Mandavia is an expert in the importance of point-of-care triage in emergency medicine.

UroGen Pharma Ltd. today announced that it will report first quarter 2022 financial results on Tuesday, May 10, 2022, prior to the open of the market.

Alpine Immune Sciences, Inc. announced that members of its management team will participate at the following investor conferences in May 2022: LifeSci Partners Immunology & Inflammation Symposium Date: Tuesday, May 10, 2022 Time: 3:00 p.m. ET/12:00 p.m.

Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company will report its first quarter 2022 financial results and provide a corporate update on Wednesday, May 11, 2022.

CorMedix Inc. today announced that it will report its financial results for the first quarter ended March 31, 2022, after the market close on Thursday, May 12, 2022, and will host a corporate update conference call at 4:30pm Eastern Time.